Do Patients With Lennox-Gastaut Syndrome Respond Differently to Diazepam Nasal Spray (Valtoco®) Than Other Patients with Pediatric Encephalopathies? Final Safety and Effectiveness Results From a Phase 3, Long-Term Open-Label, Repeat-Dose Safety Study

被引：0
|
作者：
Tarquinio, D.
Wheless, J.
Segal, E.
Misra, S.
Rabinowicz, A.
Carrazana, E.
机构：
来源：
ANNALS OF NEUROLOGY | 2022年 / 92卷
关键词：
Epilepsy/Sleep;
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
43
引用
收藏
页码：S73 / S75
页数：3
相关论文
共 50 条
  • [31] Safety and pharmacokinetic profile of rufinamide in pediatric patients aged less than 4 years with Lennox-Gastaut syndrome: An interim analysis from a multicenter, randomized, active-controlled, open-label study
    Arzimanoglou, Alexis
    Ferreira, Jose A.
    Satlin, Andrew
    Mendes, Shannon
    Williams, Betsy
    Critchley, David
    Schuck, Edgar
    Hussein, Ziad
    Kumar, Dinesh
    Dhadda, Shobha
    Bibbiani, Francesco
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2016, 20 (03) : 393 - 402
  • [32] Examining the Patient Experience With Diazepam Nasal Spray for Seizure Clusters: Patient-reported Results From an Exit Survey of a Phase 3, Open-label, Repeat Dose Safety Study
    Penovich, Patricia
    Wheless, James
    Hogan, R. Edward
    Guerra, Cynthia
    Cook, David F.
    Carrazana, Enrique
    Rabinowicz, Adrian L.
    NEUROLOGY, 2021, 96 (15)
  • [33] Long-term safety and efficacy of Cannabidiol (CBD) treatment in Lennox Gastaut syndrome: results overall and for patients completing 1-3 years of an open-label extension (GWPCARE5)
    Chin, R.
    Gil-Nagel, A.
    Mitchell, W.
    Patel, A. D.
    Perry, M. S.
    Weinstock, A.
    Checketts, D.
    Dunayevich, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2020, 27 : 24 - 24
  • [34] Long-Term Safety and Efficacy of Cannabidiol (CBD) Treatment in Patients with Lennox Gastaut Syndrome (LGS): 3-Year Results of an Open-Label Extension (OLE) Trial (GWPCARE5)
    Patel, Anup
    Chin, Richard
    Mitchell, Wendy
    Perry, Scott
    Weinstock, Arie
    Checketts, Daniel
    Dunayevich, Eduardo
    NEUROLOGY, 2020, 94 (15)
  • [35] LONG-TERM SAFETY AND EFFICACY OF RISANKIZUMAB TREATMENT IN PATIENTS WITH CROHN'S DISEASE: FINAL RESULTS FROM THE PHASE 2 OPEN-LABEL EXTENSION STUDY
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip J.
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, Weijiang
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    GASTROENTEROLOGY, 2020, 158 (06) : S1198 - S1198
  • [36] Long-term safety and efficacy of risankizumab treatment in patients with Crohn's disease: Final results from the Phase 2 open-label extension study
    Ferrante, M.
    Feagan, B. G.
    Panes, J.
    Baert, F.
    Louis, E.
    Dewit, O.
    Kaser, A.
    Duan, W. R.
    Gustafson, D.
    Liao, X.
    Wallace, K.
    Kalabic, J.
    D'Haens, G. R.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S024 - S025
  • [37] Long-term safety and efficacy of lanreotide autogel in Japanese patients with neuroendocrine tumors: Final results of a phase II open-label extension study
    Ito, Tetsuhide
    Fujimori, Nao
    Honma, Yoshitaka
    Kudo, Atsushi
    Hijioka, Susumu
    Katsushima, Shinji
    Kimura, Yasutoshi
    Fukutomi, Akira
    Hisamatsu, Seiichi
    Nakajima, Akihiro
    Shimatsu, Akira
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2021, 17 (05) : E153 - E161
  • [38] Long-term safety of cyclical rozanolixizumab in patients with generalized myasthenia gravis: Results from the Phase 3 MycarinG study and an open-label extension
    Habib, Ali A.
    Druzdz, Artur
    Grosskreutz, Julian
    Mantegazza, Renato
    Sacconi, Sabrina
    Utsugisawa, Kimiaki
    Vu, Tuan
    Vissing, John
    Gayfieva, Maryam
    Pulido-Valdeolivas, Irene
    Tarancon, Thais
    Woltering, Franz
    Bril, Vera
    JOURNAL OF NEUROMUSCULAR DISEASES, 2025,
  • [39] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
    Alan Kivitz
    Alvin F. Wells
    Juan I. Vargas
    Herbert S. B. Baraf
    Maureen Rischmueller
    Justin Klaff
    Nasser Khan
    Yihan Li
    Kyle Carter
    Alan Friedman
    Patrick Durez
    Rheumatology and Therapy, 2023, 10 : 901 - 915
  • [40] Long-Term Efficacy and Safety of Upadacitinib in Patients with Rheumatoid Arthritis: Final Results from the BALANCE-EXTEND Open-Label Extension Study
    Kivitz, Alan
    Wells, Alvin F. F.
    Vargas, Juan I. I.
    Baraf, Herbert S. B.
    Rischmueller, Maureen
    Klaff, Justin
    Khan, Nasser
    Li, Yihan
    Carter, Kyle
    Friedman, Alan
    Durez, Patrick
    RHEUMATOLOGY AND THERAPY, 2023, 10 (04) : 901 - 915
12345